| |
| |
|
| Insider
Information: |
Browne L Daniel |
| Relationship: |
CEO and President, Dir... |
| City: |
Newark |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
152,193 |
|
|
Indirect Shares
|
409 |
|
|
| Direct
Value |
$480,930 |
|
|
|
Indirect Value
|
$1,292 |
|
|
| Total
Shares |
152,602 |
|
|
| Total
Value |
$482,222 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Revance Therapeutics, Inc. |
RVNC |
CEO and President, Dir... |
2019-06-28 |
152,193 |
2019-06-28 |
409 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RVNC |
Revance Therapeutics, Inc... |
CEO and PresidentOfficer |
• • – |
2014-02-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
53,333 |
|
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2014-02-11 |
4 |
A |
$0.00 |
$0 |
I/I |
17,702 |
71,035 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2014-05-19 |
4 |
A |
$32.22 |
$3,093,120 |
D/D |
96,000 |
166,626 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2014-11-28 |
4 |
B |
$16.67 |
$100,019 |
D/D |
6,000 |
172,626 |
2.81 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2015-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
43,500 |
217,126 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2015-05-19 |
4 |
D |
$25.94 |
$311,929 |
D/D |
(12,025) |
205,101 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2015-06-30 |
4 |
A |
$14.16 |
$14,160 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2015-12-30 |
4 |
OE |
$2.55 |
$30,715 |
D/D |
12,045 |
218,415 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2015-12-31 |
4 |
A |
$27.00 |
$7,074 |
D/D |
262 |
218,677 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2016-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
243,677 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2016-05-19 |
4 |
D |
$17.11 |
$206,176 |
D/D |
(12,050) |
231,627 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2016-10-26 |
4 |
AS |
$14.85 |
$178,199 |
D/D |
(12,000) |
219,627 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2016-11-25 |
4 |
AS |
$17.86 |
$215,005 |
D/D |
(12,000) |
207,627 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2016-12-28 |
4 |
AS |
$20.94 |
$251,250 |
D/D |
(12,000) |
195,627 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2016-12-30 |
4 |
A |
$11.58 |
$11,577 |
D/D |
1,000 |
196,627 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-01-25 |
4 |
AS |
$19.78 |
$237,398 |
D/D |
(12,000) |
184,627 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
25,800 |
210,427 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-02-22 |
4 |
AS |
$20.56 |
$227,050 |
D/D |
(11,037) |
199,390 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-03-16 |
4 |
D |
$19.20 |
$60,885 |
D/D |
(3,171) |
196,219 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-05-22 |
4 |
AS |
$20.20 |
$248,159 |
D/D |
(12,287) |
183,932 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-05-24 |
4 |
AS |
$20.35 |
$401,091 |
D/D |
(19,713) |
164,219 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-05-30 |
4 |
OE |
$2.55 |
$12,750 |
D/D |
5,000 |
169,219 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-06-12 |
4 |
OE |
$2.55 |
$21,165 |
D/D |
8,300 |
177,519 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-06-30 |
4 |
A |
$18.32 |
$18,318 |
D/D |
1,000 |
178,519 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-08-23 |
4 |
OE |
$2.55 |
$844 |
D/D |
331 |
178,850 |
0 |
- |
|
44 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
